Christofer Natale Buatti DO FAAD, FAOCD, FACOI, CAQH-MOHS
Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology
CEO and MOHS Surgery/ Medical Director of Oakland Hills Dermatology
Join to View Full Profile
3400 Auburn RdSte 100Auburn Hills, MI 48326
Phone+1 248-858-2255
Fax+1 248-499-7436
Dr. Buatti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christofer Buatti, DO, is a dermatology specialist located in Auburn Hills, MI. His subspecialties include Cosmetic Dermatology, Dermatologic Surgery, and Pediatric Dermatology. He completed his medical degree at Des Moines University College of Osteopathic Medicine in 2004 and his BS in Physiology from Michigan State University in 1997. He is currently an Assistant Clinical Professor at Michigan State University and a practicing Dermatologist at Oakland Hills Dermatology PC. Dr. Buatti has experience in sclerotherapy, general dermatology, dermatitis, psoriasis, and chronic plaque psoriasis. He has been a Principal Investigator on clinical trials and is recognized as a Fellow by the American Academy of Dermatology.
Education & Training
Des Moines University College of Osteopathic MedicineClass of 2004
Michigan State UniversityBS, Physiology , Top 5 percent, 1993 - 1997
Certifications & Licensure
MI State License 2004 - 2028
AOA Board of Dermatology Dermatology- AOA Board of Dermatology MOHS-Micrographic Surgery (CAQ)
AOBD MOHSCAQM MOHS
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EMA Mobile, Modernizing Medicine, Inc., 2013-2017
- CMS Meaningful Use Stage 2 Certification EMA, Modernizing Medicine, Inc., 2013-2017
- CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2013-2017
Clinical Trials
- Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study Start of enrollment: 2019 May 29
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Professional Memberships
- Fellow
- Member
- Member
- Member
- Fellow
External Links
- Oakland Hills Dermatologyhttp://Oaklandhillsdermatogy.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
